Poland· PL-100471270

Scandivin

A mepivacaine product containing mepivacaini hydrochloridum, registered in Poland by Laboratorios Inibsa S.A.. The same ATC class is registered in 18 of our 19 countries.

ATC N01BB03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedScandivinATCN01BB03REGISTER NO.PL-100471270PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Mepivacaine is registered in 18 of 19 countries.

Countries holding a registration under ATC N01BB03 (mepivacaine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose

Mepivacaine · ATC N01BB03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Mepivacaini hydrochloridum
Manufacturer
Laboratorios Inibsa S.A.
Country
Poland (PL)
ATC code
N01BB03
ATC class
Mepivacaine
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    08410840052923

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

24 interactions on record for mepivacaine.

Graded by severity as the source publishes them — 23 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Mepivacaine · interactions on record

24 records

  • 23 moderate
  • 1 minor

Most severe, free to view

  • LidocainA01AE01moderate
  • TetracainA01AE02moderate
  • LidocaineC05AD01moderate
  • TetracaineC05AD02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mepivacaine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mepivacaine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Mepinaest Purum, Scandonest Ohne Vasokonstriktor
  • Belgium · Mepicart, Mepivastesin
  • Bulgaria · Мепидентал, Скандонест
  • Cyprus · Imeros, Mepidental
  • Czechia · Scandonest
  • Germany · Meaverin, Mecain
  • Denmark · Carbocain, Mepidental
  • Estonia · Scandivin, Scandonest
  • Spain · Isogaine, Mepivacaína B. Braun
  • Finland · Mepidental, Scandonest
  • France · Carbocaine, Mepivacaine B. Braun
  • United Kingdom (Northern Ireland) · Biocaine Plain, Mepivacaine Hydrochloride Accord Healthcare
  • Greece · Imeros, Scandonest
  • Croatia · Scandonest
  • Hungary · Scandonest
  • Ireland · Scandonest
  • Iceland · Carbocain, Carbocain Dental
  • Italy · Carbosen, Mepicain
  • Lithuania · Mepivastesin, Scandivin
  • Luxembourg · Mepicart, Scandicaïne
  • Latvia · Scandivin, Scandonest
  • Netherlands · Imeros, Mepicart
  • Norway · Carbocain Dental, Scandonest Plain
  • Portugal · Isogaine, Mepivacaína Braun
  • Romania · Mepidental, Mepivacaina Normogen
  • Sweden · Carbocain, Carbocain Dental
  • Slovenia · Scandicaine
  • Slovakia · Mepivastesin, Scandonest

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be1b6123-2455-405f-aeec-03f2004f73cd
GET /v1/drugs/be1b6123-2455-405f-aeec-03f2004f73cd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań we wkładzie",
  "source": "urpl",
  "strength": "30 mg/ml",
  "packaging": "08410840052923 ¦ Rp ¦ 150860\n50 wkładów 1,8 ml",
  "substance": "Mepivacaini hydrochloridum 30 mg/ml",
  "common_name": "Mepivacaini hydrochloridum",
  "pl_product_id": "100471270",
  "pozwolenie_nr": "27943",
  "auth_procedure": "DCP",
  "authorisation_validity": "2028-07-28"
}

See everything about mepivacaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.